scholarly journals Protruding left atrial myxoma presented with congestive heart failure and transient ischemic attack

2004 ◽  
Vol 27 (11) ◽  
pp. 605-605
Author(s):  
Mi-Seung Shin ◽  
Wook-Jin Chung ◽  
Kwang Kon Koh ◽  
Young Mi Yun ◽  
Kyu Jin Oh ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Transient Ischemic Attack ◽  
Left Atrial ◽  
Atrial Myxoma ◽  
Left Atrial Myxoma ◽  
Ischemic Attack

scholarly journals Cerebral embolization from left atrial myxoma causing takotsubo cardiomyopathy complicated with congestive heart failure

2020 ◽  
Vol 27 (4) ◽  
pp. 439-440
Author(s):  
Takao Konishi ◽  
Naohiro Funayama ◽  
Tadashi Yamamoto ◽  
Daisuke Hotta ◽  
Shinya Tanaka
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Takotsubo Cardiomyopathy ◽  
Left Atrial ◽  
Atrial Myxoma ◽  
Left Atrial Myxoma ◽  
Cerebral Embolization

scholarly journals Left Atrial Myxoma Associated with Severe Congestive Heart Failure, Pulmonary Hypertension, and Multiple Organ Insufficiency.

1995 ◽  
Vol 36 (6) ◽  
pp. 829-834 ◽  
Author(s):  
Toshihide NAKANO ◽  
Hisanori MAYUMI ◽  
Shigeki MORITA ◽  
Kiminori SHIRAISHI ◽  
Yasuo KANEGAE ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Pulmonary Hypertension ◽  
Left Atrial ◽  
Severe Congestive Heart Failure ◽  
Multiple Organ ◽  
Atrial Myxoma ◽  
Left Atrial Myxoma

Massive left atrial myxoma induced congestive heart failure

2017 ◽  
Vol 32 (7) ◽  
pp. 420-421 ◽  
Author(s):  
Michele Gallo ◽  
Jaimin R. Trivedi ◽  
Adam N. Protos ◽  
Mark S. Slaughter
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Left Atrial ◽  
Atrial Myxoma ◽  
Left Atrial Myxoma

LEFT ATRIAL MYXOMA IN A CHILD

PEDIATRICS ◽  
1972 ◽  
Vol 49 (4) ◽  
pp. 580-589
Author(s):  
William E. Steinke ◽  
Lowell W. Perry ◽  
Harvey R. Gold ◽  
James E. McClenathan ◽  
Lewis P. Scott
Keyword(s):  
Heart Failure ◽  
Mitral Regurgitation ◽  
Medical Therapy ◽  
Sedimentation Rate ◽  
Left Atrial ◽  
Serum Proteins ◽  
Atrial Myxoma ◽  
Left Atrial Myxoma ◽  
Incorrect Diagnosis ◽  
Elevated Sedimentation Rate

A 9-year-old female presented with mitral regurgitation, heart failure, fever, abnormal serum proteins, elevated sedimentation rate, and elevated antihyaluronidase titer. At first thought to have rheumatic fever, she initially responded favorably to medical therapy which included corticosteroids. Evidence of progressive disease led to cardiac catheterization and angiography which demonstrated a left atrial myxoma which was successfully excised. Review of the literature reveals that 23 children with left atrial myxomas have been reported. These may present with embolic, obstructive, or constitutional symptoms. Most children have clinical evidence of mitral regurgitation. Associated heart failure, anemia, elevated sedimentation rate, elevated antihyaluronidase titer and initial favorable response to medical therapy often lead to the incorrect diagnosis of acute or chronic rheumatic heart disease. In these patients, increased endogenous hyaluronic acid excretion from tumor cells may lead to increased hyaluronidase and antihyaluronidase activity, abnormal serum proteins and elevated sedimentation rate.

scholarly journals Acute heart failure related to a large left atrial myxoma

2018 ◽  
Vol 31 (3) ◽  
pp. 331-333
Author(s):  
Giovanni A. Chiariello ◽  
Piergiorgio Bruno ◽  
Christian Colizzi ◽  
Natalia Pavone ◽  
Marialisa Nesta ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Left Atrial ◽  
Atrial Myxoma ◽  
Left Atrial Myxoma

A Retrospective Study of Current Anticoagulant Use in Patients with Atrial Fibrillation: Results from a Managed Care Database.

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 2246-2246
Author(s):  
Miranda Murray ◽  
Howard Friedman
Keyword(s):  
Risk Factors ◽  
Heart Failure ◽  
Atrial Fibrillation ◽  
Congestive Heart Failure ◽  
Managed Care ◽  
Anticoagulant Therapy ◽  
Transient Ischemic Attack ◽  
Clinical Care ◽  
Significant Risk ◽  
Ischemic Attack

Abstract The vitamin K antagonist warfarin is currently the mainstay of anticoagulant therapy for patients with atrial fibrillation (AF), in whom it has been shown to be effective in preventing stroke. However, it is underused because, despite the quality of clinical care, warfarin can be a difficult drug to manage well. When initiating therapy, patients may require several visits to a coagulation clinic to achieve an international normalized ratio (INR) within the safe and effective range (INR 2–3). Thereafter, frequent monitoring of patients receiving warfarin may still be required due to intrapatient variability. Despite the benefits, studies have shown that approximately 50% of patients who should receive warfarin are not prescribed it or do not receive it. This study was performed to investigate the use of warfarin in eligible patients with AF, for whom it was indicated. Using the US PharMetrics database from 51 managed care organizations, data entered between January 1997 and April 2004, from 5940 patients (>18 years of age with a diagnosis of AF [ICD 9] for whom warfarin was indicated), were analyzed. Patients were excluded if they were not in the database 30 days before and 120 days after their initial diagnosis of AF. Patients were divided into four distinct cohorts, based on treatment patterns: steady users (at least 3 months of warfarin use); discontinued users (used warfarin for only 3 months); non-users (warfarin use for <30 days); and intermittent users (used warfarin prior to first diagnosis of AF, or had less than two prescriptions). Analysis showed that only 31% (1854) of patients were steady users, whereas 59% (3521) of patients were non-users. Also, 4% (246) and 5% (319) of patients were discontinued users and intermittent users, respectively. In addition to a diagnosis of AF, many patients had significant risk factors for stroke: hypertension (48%); diabetes (23%); congestive heart failure (21%); age 75 or older (19%); history of stroke or transient ischemic attack (7%). However, the study showed that patients prescribed warfarin did not have more risk factors compared with long-term steady warfarin users and warfarin non-users (see table). Overall, this study shows that warfarin is underused, even in patients with significant risk factors for stroke, which highlights the need for new, simpler, oral anticoagulant therapy. Risk factors Total population [n (%)] Steady warfarin (%) Discontinued (%) Non-warfarin (%) Intermittent (%) NB Cumulative numbers of risk factors were constructed by assigning one point for each of the following: congestive heart failure; hypertension; age >75; diabetes; with two points added for prior stroke or transient ischemic attack 0 2036 (32) 32 29 36 34 1 1774 (30) 30 27 30 30 2 1197 (20) 22 23 19 23 3 623 (10) 11 13 10 8 4 204 (3) 3 4 4 4 5/6 106 (2) 2 3 1 1

scholarly journals Left Atrial Myxoma in a Woman with Postpartum Heart Failure: The Culprit or an Incidental Bystander

2018 ◽  
Vol 07 (01) ◽  
pp. 63-69
Author(s):  
Musa Mohammed Baba ◽  
Mohammed Abdullahi Talle ◽  
Faruk Buba ◽  
Kabir M. Fagge
Keyword(s):  
Heart Failure ◽  
Left Atrial ◽  
Atrial Myxoma ◽  
Left Atrial Myxoma
Sign in / Sign up

Export Citation Format

Share Document